Independent variables | Dependent variable |
---|
| HEPA (n = 79) | No HEPA (n = 449) | No HEPA |
---|
Mean (SD) | OR 95% CI | p value |
---|
Age, years | 55.5 (10.7) | 59.3 (12.0) | 1.03 (1.01;1.05) | 0.008 |
SpA subgroup | | | | |
AS | | | 1 | |
PsA | 0.80 (0.45; 1.43) | 0.448 |
USpA | 0.95 (0.43; 2.06) | 0.886 |
EQ-5D (0–1)a | 0.67 (0.25) | 0.62 (0.28) | 0.47 (0.17;1.29) | 0.144 |
BASDAI (0–10) | 3.9 (2.3) | 4.5 (2.2) | 1.13 (1.01;1.26) | 0.027 |
BASFI (0–10) | 2.8 (2.4) | 3.9 (2.5) | 1.19 (1.06; 1.33) | 0.003 |
Pain (0–10) | 4.1 (2.7) | 4.7 (2.5) | 1.09 (0.99; 1.20) | 0.084 |
Fatigue (0–10) | 4.8 (3.0) | 5.4 (2.6) | 1.10 (1.01; 1.21) | 0.031 |
HADs anxiety (0–21) | 5.8 (4.9) | 6.0 (4.5) | 1.02 (0.96; 1.08) | 0.544 |
HADs depression (0–21) | 4.4 (4.2) | 4.7 (3.5) | 1.04 (0.97; 1.11) | 0.330 |
- Logistic regression analyses presented with odds ratio (OR) and 95% CI. Age and SpA subgroup were included in all analyses, and all other variables were added separately and adjusted for age and SpA subgroup. Number of patients included in sub-analyses (range: n = 528–497)
- HEPA health-enhancing physical activity, SpA spondyloarthritis, AS ankylosing spondylitis, PsA psoriatic arthritis, USpA undifferentiated spondyloarthritis, EQ-5D EuroQoL 5-dimensions, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Functional Index, HADs Hospital Anxiety and Depression scale
- aUtilities calculated by the British time trade-off-based preference set. Missing data: EQ-5D: 66 (5%), BASDAI: 31 (2%), BASFI: 24 (1.7%), Pain/Fatigue 5 (0.3%), HADs anxiety/depression: 9 (0.6%)